Goji berries have been used in traditional medicine for centuries, but we know surprisingly little about which components actually work and how. This study focused on water-soluble polysaccharides (LBPs) extracted from Lycium barbarum, testing whether they could extend lifespan and improve healthy aging in C. elegans—a 1-mm roundworm commonly used in aging research because its genetics and aging process are well-characterized and partly conserved in humans.
The researchers treated worms with purified LBPs at a concentration of 700 μg/mL and measured multiple outcomes: lifespan (the primary endpoint), and healthspan markers including muscle function (locomotion), resistance to heat and oxidative stress, accumulation of cellular waste (lipofuscin), and fat storage. They also used genetic mutants and transgenic strains to pinpoint which molecular pathways were responsible for the benefits.
The results were encouraging within the worm model. LBPs increased mean lifespan by 20.67% (statistically significant at p < 0.01) and improved all tested healthspan measures. Mechanistically, the team showed the effects depended on three key transcription factors—DAF-16/FOXO, SKN-1/Nrf2, and HSF-1—that regulate stress resistance and longevity. Critically, benefits were abolished or greatly reduced in worms with mutations in the insulin/IGF-1 signaling (IIS) pathway, implicating this ancient metabolic control system. The researchers also found altered expression of genes governing lipid metabolism, particularly desaturases (fat-6, fat-7, fat-5), suggesting LBPs rewire how cells handle fats.
Important limitations deserve emphasis. This is a single-species, in vivo model study in an organism with ~300 neurons and a 2–3 week lifespan—far removed from human biology. No data on bioavailability, dose-response in mammals, or safety in humans are provided. The study has not yet been replicated by independent groups. The mechanism, while mechanistically detailed for C. elegans, relies on pathway manipulation in worms; whether LBPs actually activate these pathways in human cells or tissues remains untested. Publication date (April 2026) suggests very recent work with zero citations—the findings have not yet entered the scientific literature's feedback loop.
Within longevity research, this work is valuable as a proof-of-concept that goji berry compounds can activate well-conserved, pro-longevity pathways in a tractable model organism. The focus on lipid remodeling and IIS is noteworthy because these pathways are genuine targets in aging biology. However, the leap from a 21% lifespan extension in worms to clinical relevance in humans is enormous. The next steps would be cell culture validation, mammalian studies (likely mouse), and eventually human trials—none of which have been reported.
For someone considering goji berry supplementation based on this paper alone: this is interesting basic biology but not yet evidence of human benefit. Goji berries are generally safe and are foods, not drugs, so risk is low—but this paper does not establish they extend human lifespan or healthspan.
0 Comments
Log in to join the discussion.